Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Auctus Global Capital is a private investment and business development firm based in Newport Beach, California, focused on financing and acquiring small to lower middle-market companies. The firm operates across multiple sectors including life sciences, medical devices, clean technology, and information technology, with a stated emphasis on cross-border transactions linking U.S. companies with partners and capital sources in Asia. In healthcare, Auctus appears to be primarily an investor and strategic partner rather than a drug developer, with representative portfolio exposure to ophthalmic and vascular medical device companies such as LensGen and Laser Associated Sciences. The company also states it launched an incubator at the University of California, Irvine focused on medical device and healthcare technologies. Overall, Auctus should be viewed as a diversified investment platform with some healthcare and medtech activity, not as a biotech or pharmaceutical operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Auctus Global Capital.